Nesina
These highlights do not include all the information needed to use NESINA safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013
a3768c7e-aa4c-44d3-bc53-43bb7346c0b0
HUMAN PRESCRIPTION DRUG LABEL
Aug 7, 2023
Takeda Pharmaceuticals America, Inc.
DUNS: 039997266
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
alogliptin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
alogliptin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
alogliptin
Product Details
FDA regulatory identification and product classification information